Seed VC · USA

Impact Science Ventures

Active

What they invest in

Industrial capitalists building disruptive companies driving industrial innovation in trillion-dollar global markets. ISV identifies, invests in and builds breakout companies commercializing scientific breakthroughs to disrupt trillion-dollar markets, working with portfolio founders to accelerate technology de-risking, verify product market fit, and reduce time/resources to market.

Who they back

DeepTechAIElectronicsIndustry 4.0 / RoboticsEnergyMaterialsHealthtechBiotechSeries ASeries B+

Business models

deeptech_ip, hardware

Customer segments

Enterprise

Geography

US

Recent investments

  • Twelve
  • ACT
  • Resonant Link Medical

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

7 partners on file at Impact Science Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Impact Science Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Impact Science Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Jan 2023
Website
impactscience.vc ↗
LinkedIn
Firm profile ↗

Other firms investing in DeepTech

See all investors

Is Impact Science Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Impact Science Ventures is one of them, and we'll tell you exactly where they sit in your top 100.